A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer

Gynecologic Oncology

Volumn 131, Issue 2, 2013, Pages 389-394

  Hynninen, Johanna ^a   Kemppainen, Jukka ^a   Lavonius, Maija ^a   Virtanen, Johanna ^a   Matomäki, Jaakko ^a   Oksa, Sinikka ^b   Carpén, Olli ^c   Grénman, Seija ^a   Seppänen, Marko ^a   Auranen, Annika ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b SATAKUNTA CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Operability; Ovarian cancer; PET CT; Preoperative imaging; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ABDOMINAL DISEASE; ADULT; ADVANCED CANCER; ADVANCED EPITHELIAL OVARIAN CANCER; AGED; ARTICLE; CANCER PROGNOSIS; CARCINOMATOSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCED COMPUTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; HUMAN TISSUE; MESENTERY; OVARY CARCINOMA; PERITONEAL CAVITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMALL INTESTINE;

OPERABILITY; OVARIAN CANCER; PET/CT; PREOPERATIVE IMAGING; STAGING;

AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84886089147     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.08.023     Document Type: Article

References (27)

1. S.J. Chang, and R.E. Bristow Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining 'optimal' residual disease Gynecol Oncol 125 May 2012 483 492
2. E.L. Eisenhauer, N.R. Abu-Rustum, Y. Sonoda, D.A. Levine, E.A. Poynor, and C. Aghajanian The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer Gynecol Oncol 103 12 2006 1083 1090
3. G.D. Aletti, S.C. Dowdy, B.S. Gostout, M.B. Jones, C. Robert Stanhope, and Timothy O. Wilson Aggressive surgical effort and improved survival in advanced-stage ovarian cancer Obstet Gynecol 107 January 2006 77 85
4. I. Vergote, A. du Bois, F. Amant, F. Heitz, K. Leunen, and P. Harter Neoadjuvant chemotherapy in advanced ovarian cancer: on what do we agree and disagree? Gynecol Oncol 128 Jan 2013 6 11
5. S.C. Dowdy, S.A. Mullany, K.R. Brandt, B.J. Huppert, and W.A. Cliby The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma Cancer 101 2004 346 352
6. R.E. Bristow, L.R. Duska, N.C. Lambrou, E.K. Fishman, M.J. O'Neill, and E.L. Trimble A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography Cancer 89 Oct 1 2000 1532 1540
7. A.E. Axtell, M.H. Lee, R.E. Bristow, S.C. Dowdy, W.A. Cliby, and S. Raman Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer J Clin Oncol 25 February 1, 2007 384 389
8. O. Gemer, M. Gdalevich, M. Ravid, B. Piura, A. Rabinovich, and T. Gasper A multicenter validation of computerized tomography models as predictors of non- optimal primary cytoreduction of advanced epithelial ovarian cancer Eur J Surg Oncol 35 10 2009 1109 1112
9. E.J. Nam, M.J. Yun, Y.T. Oh, J.W. Kim, J.H. Kim, and S. Kim Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI Gynecol Oncol 116 Mar 2010 389 394
10. P. Castellucci, A.M. Perrone, M. Picchio, T. Ghi, M. Farsad, and C. Nanni Diagnostic accuracy of 18 F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology Nucl Med Commun 28 Aug 2007 589 595
11. S. Risum, C. Hogdall, A. Loft, A.K. Berthelsen, E. Hogdall, and L. Nedergaard Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer? Gynecol Oncol 116 Mar 2010 395 398
12. J. Hynninen, A. Auranen, O. Carpen, K. Dean, M. Seppanen, and J. Kemppainen FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread Gynecol Oncol 126 Jul 2012 64 68
13. S. Risum, C. Høgdall, A. Loft, A.K. Berthelsen, E. Høgdall, and L. Nedergaard Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography - a prospective study Gynecol Oncol 108 2 2008 265 270
14. J. Hynninen, M. Lavonius, S. Oksa, S. Grénman, O. Carpén, and A. Auranen Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy? Gynecol Oncol 128 2 2013 229 232
15. A. Fagotti, G. Ferrandina, F. Fanfani, A. Ercoli, D. Lorusso, and M. Rossi A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study Ann Surg Oncol 13 Aug 2006 1156 1161
16. A. Fagotti, G. Ferrandina, F. Fanfani, G. Garganese, G. Vizzielli, and V. Carone Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma Am J Obstet Gynecol 199 Dec 2008 642.e1 642.e6
17. V.L. Durkalski, Y.Y. Palesch, S.R. Lipsitz, and P.F. Rust Analysis of clustered matched-pair data Stat Med 22 Aug 15 2003 2417 2428
18. A. Pereira, J.F. Magrina, V. Rey, M. Cortes, and P.M. Magtibay Pelvic and aortic lymph node metastasis in epithelial ovarian cancer Gynecol Oncol 105 6 2007 604 608
19. S. Kyriazi, S.B. Kaye, and N.M. deSouza Imaging ovarian cancer and peritoneal metastases-current and emerging techniques Nat Rev Clin Oncol 7 Jul 2010 381 393
20. G. Glaser, M. Torres, B. Kim, G. Aletti, A. Weaver, and A. Mariani The use of CT findings to predict extent of tumor at primary surgery for ovarian cancer Gynecol Oncol 130 Aug 2013 280 283
21. C. Pfannenberg, I. Konigsrainer, P. Aschoff, M.O. Oksuz, D. Zieker, and S. Beckert (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Ann Surg Oncol 16 May 2009 1295 1303
22. P. De Iaco, A. Musto, L. Orazi, C. Zamagni, M. Rosati, and V. Allegri FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy Eur J Radiol 80 11 2011 e98 e103
23. K. Kitajima, K. Murakami, E. Yamasaki, Y. Kaji, I. Fukasawa, and N. Inaba Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT Eur J Nucl Med Mol Imaging 35 Oct 2008 1912 1920
24. H. Bonnefoi, R.P. A'Hern, C. Fisher, V. Macfarlane, D. Barton, and P. Blake Natural history of stage IV epithelial ovarian cancer J Clin Oncol 17 Mar 1999 767 775
25. E.D. Rappeport, and A. Loft Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography Abdom Imaging 32 Sep-Oct 2007 624 634
26. Y. Satoh, T. Ichikawa, U. Motosugi, K. Kimura, H. Sou, and K. Sano Diagnosis of peritoneal dissemination: comparison of 18 F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT AJR Am J Roentgenol 196 Feb 2011 447 453
27. M. Soussan, G. Des Guetz, V. Barrau, V. Aflalo-Hazan, G. Pop, and Z. Mehanna Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy Eur Radiol 22 Jul 2012 1479 1487